The Prime Biologics Forecast Scenario is just more of the same...

The Prime Biologics Forecast Scenario is just more of the same old, same old.

It is a wish list!

I do not recall one of these types of presentations over the last five years EVER COMING OFF IN FULL!

The 'valuation' of S$66.5 million is a disgrace. It is at this stage a hopeful outcome - not a valuation.

We will see what investors are prepared to stump up shortly.

One of the main issues that NSP has the the lack of credibility of our directors/management and their failure to respond to legitimate questions raised by shareholders.

They sweep everything 'under the carpet' and then every year grab more emoluments for themselves - and most of this comes from the SPP's and/or revaluation of assets!

DYOR

Regards.................